Association of Procalcitonin with the Patient’s Infection Characteristics and Prognosis after Hematopoietic Stem Cell Transplantation

Table 4

Comparison of inflammatory and biochemical indicators between patients whose condition showed improvement and those who died.

	Improvement ()	Died ()
PCT (ng/mL)	0.66 (0.24, 6.94)	2.16 (0.76, 23.84)	<0.05
CRP (mg/L)	82.66 (35.52, 123.81)	69.39 (40.88, 172.75)	<0.05
WBC (10^9 cells/L)	0.01 (0.00, 0.31)	0.39 (0.02, 10.31)	<0.05
Hb (g/L)	81.50 (76.00, 89.00)	92.00 (68.25, 101.00)	0.265
D-Dimer (mg/mL)	449.00 (261.25, 800.00)	1841.00 (524.00, 3907.50)	<0.05
AST (U/L)	38.00 (23.75, 55.50)	41.50 (23.75, 80.75)	0.431
ALT (U/L)	23.00 (16.75, 40.00)	41.00 (24.66, 75.00)	<0.05
LDH (U/L)	163.00 (128.00, 218.75)	394.50 (235.00, 734.00)	<0.05
ALP (U/L)	66.00 (50.75, 92.50)	67.00 (47.50, 208.00)	0.064
CK (U/L)	20.50 (15.30, 25.00)	59.50 (25.75, 220.00)	<0.05
ALB (g/L)	34.25 (31.60, 37.20)	29.30 (26.53, 35.43)	<0.05
CRE (μmol/L)	57.50 (44.00, 75.50)	82.00 (52.50, 110.75)	<0.05
Age (years)	41.50 (26.00, 52.00)	34.00 (25.00, 48.25)	0.960
Body temperature	38.70 (37.90, 39.00)	38.45 (37.08, 39.20)	0.480
BUN (mmol/L)	5.06 (3.58, 6.92)	14.58 (6.35, 16.72)	<0.05
BNP (p g/mL)	102.00 (37.13, 406.13)	844.25 (287.50, 1612.50)	<0.05
GLU (mmol/L)	6.36 (5.06, 8.28)	7.35 (5.15, 9.76)	<0.05
Agranulocytosis (%)	100 (159) 62.9%	19 (39) 48.7%	—